Deal set to create world’s third-biggest premium spirits company
Like this page on Facebook for updates
Thursday 30 May 2013
A £52m refit for BBC's Bush House
Saturday 18 May 2013
Saturday 23 March 2013
In a few weeks time we will know if the UK has entered a dreaded triple-dip recession. So wouldn't it be good if you could assemble a portfolio of shares that could weather an economic downturn?
Tuesday 05 February 2013
Pharmaceutical giant shocks medical world by opting to reveal findings of all tests on patients
Wednesday 12 December 2012
Is AstraZeneca's chief executive, Pascal Soriot, ready for an eyesight test? Analysts at Kepler think Mr Soriot could be one of a number of pharmaceutical company bosses eyeing up Bausch & Lomb, the US eye-care company. Private equity firm Warburg Pincus has hired Goldman Sachs to sell the contact lenses and eye-surgery equipment specialist.
Tuesday 27 November 2012
Britain's biggest drugs maker, GlaxoSmithKline (GSK), yesterday raised its stake in its Nigerian and Indian consumer healthcare units as part of boss Sir Andrew Witty's attempt to shift it away from "white pills in Western markets".
Friday 26 October 2012
GlaxoSmithKline Our view: Keep buying
Wednesday 17 October 2012
The Bumi drama highlights how many in the City want to shine more light on foreign firms gaining from a London listing
Thursday 09 August 2012
Outlook The Church of England has taken a bold ethical stance. It has decided to sell its holding in that disgraceful outfit News Corp because of phone hacking and its lack of a proper corporate governance structure (it has only just noticed that the company is Murdoch heavy, and tends to favour family members for top jobs). The fund is run by various men of God, including David Harding of Winton Capital (personal fortune: about £800m). By lucky chance, or divine providence, the shares of News Corp rose about 50 per cent in the year between when the Church decided it was awfully bothered about News Corp's ethics and the decision to sell.
Wednesday 08 August 2012
The drugs industry has a long and inglorious history when it comes to the promotion of its products. Exaggerated claims of benefit, under-reported adverse effects and selective publication of results have featured regularly over the years.
Sunday 29 July 2012
Sunday 29 July 2012
I have heard many experts say that the best days of the pharmaceutical sector are behind it.
Friday 27 July 2012
AstraZeneca, the struggling drug maker which is without a permanent boss after its chief executive quit under shareholder pressure, yesterday had another ailment to deal with as second-quarter sales fell by a fifth.
Friday 27 July 2012
Saturday 07 July 2012
New UK station Russia Today gives a very bizarre view of Britain
By performing as African Americans or Indians, white people get to play act a kind of 'imaginary liberation', writes Michael Mark Cohen
Top Gear presenter is no stranger to foot-in-mouth controversy
New essay by JK Rowling went live on Pottermore site this morning
Pope Francis declares evolution and Big Bang theory are real and God is not 'a magician with a magic wand'
Huge surge in Ukip support after EU funding row, according to new poll
Ukip ‘exploiting grooming scandal’ to secure party’s first police chief
Nigel Farage: 'There’s nothing wrong with white people blacking up'
Maureen Lipman says 'she can't vote Labour while Ed Miliband is leader'
Muslims, immigration and teenage pregnancy: British people are ignorant about almost everything
- 1 'Nasa Confirms Six Days of Darkness in December': No, they don't - it's a hoax
- 2 Canadian actor punched in face after 'Islamophobia' experiment goes wrong in wake of Ottawa shooting
- 3 Topshop at centre of row over body image as 'shocking' skinny mannequin photo goes viral
- 4 Top Gear presenter Jeremy Clarkson criticised for beer tweet
- 5 The bubble bursts for Sodastream